These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32581704)

  • 1. GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib.
    Li J; Ma S; Chen J; Hu K; Li Y; Zhang Z; Su Z; Woodgett JR; Li M; Huang Q
    Front Mol Neurosci; 2020; 13():81. PubMed ID: 32581704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK-3 mediates nuclear translocation of p62/SQSTM1 in MPTP-induced mouse model of Parkinson's disease.
    Liu Y; Huang Q; Wei Z; Ma S; Woodgett JR; Li M; Li J
    Neurosci Lett; 2021 Oct; 763():136177. PubMed ID: 34400288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
    Zhao YF; Zhang Q; Xi JY; Li YH; Ma CG; Xiao BG
    J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.
    Luo L; Chen J; Su D; Chen M; Luo B; Pi R; Wang L; Shen W; Wang R
    Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons.
    Petit-Paitel A; Brau F; Cazareth J; Chabry J
    PLoS One; 2009; 4(5):e5491. PubMed ID: 19430525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of glycogen synthase kinase-3β with Parkinson's disease (review).
    Li DW; Liu ZQ; Chen W; Yao M; Li GR
    Mol Med Rep; 2014 Jun; 9(6):2043-50. PubMed ID: 24681994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.
    Wang W; Yang Y; Ying C; Li W; Ruan H; Zhu X; You Y; Han Y; Chen R; Wang Y; Li M
    Neuropharmacology; 2007 Jun; 52(8):1678-84. PubMed ID: 17517424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease.
    Hu K; Huang Q; Liu C; Li Y; Liu Y; Wang H; Li M; Ma S
    Neuroscience; 2019 Feb; 399():117-124. PubMed ID: 30590105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection.
    Steele L; Mannion AJ; Shaw G; Maclennan KA; Cook GP; Rudd CE; Taylor A
    iScience; 2021 Jun; 24(6):102555. PubMed ID: 34142056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Inflammatory Effect of IKK-Activated GSK-3β Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson's Disease.
    Lee S; Hong DG; Yang S; Kim J; Baek M; Kim S; Thirumalai D; Chung HY; Chang SC; Lee J
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Akt/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity.
    Fang W; Gao G; Zhao H; Xia Y; Guo X; Li N; Li Y; Yang Y; Chen L; Wang Q; Li L
    Brain Res; 2015 Mar; 1602():9-19. PubMed ID: 25150591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK-3α and GSK-3β proteins are involved in early stages of chondrocyte differentiation with functional redundancy through RelA protein phosphorylation.
    Itoh S; Saito T; Hirata M; Ushita M; Ikeda T; Woodgett JR; Algül H; Schmid RM; Chung UI; Kawaguchi H
    J Biol Chem; 2012 Aug; 287(35):29227-36. PubMed ID: 22761446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
    Huang Q; Du X; He X; Yu Q; Hu K; Breitwieser W; Shen Q; Ma S; Li M
    Exp Neurol; 2016 Mar; 277():296-304. PubMed ID: 26515688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue.
    Turkistani A; Al-Kuraishy HM; Al-Gareeb AI; Albuhadily AK; Alexiou A; Papadakis M; Elfiky MM; Saad HM; Batiha GE
    Mol Neurobiol; 2024 Sep; 61(9):7092-7108. PubMed ID: 38367137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tideglusib protects neural stem cells against NMDA receptor overactivation.
    Armagan G; Keser A; Atalayın Ç; Dagcı T
    Pharmacol Rep; 2015 Oct; 67(5):823-31. PubMed ID: 26398371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival.
    Liang MH; Chuang DM
    J Biol Chem; 2007 Feb; 282(6):3904-17. PubMed ID: 17148450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP⁺-Induced Cell Damage.
    Armagan G; Sevgili E; Gürkan FT; Köse FA; Bilgiç T; Dagcı T; Saso L
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30965670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tideglusib, a chemical inhibitor of GSK3β, attenuates hypoxic-ischemic brain injury in neonatal mice.
    Wang H; Huang S; Yan K; Fang X; Abussaud A; Martinez A; Sun HS; Feng ZP
    Biochim Biophys Acta; 2016 Oct; 1860(10):2076-85. PubMed ID: 27378458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis.
    Martínez-González L; Gonzalo-Consuegra C; Gómez-Almería M; Porras G; de Lago E; Martín-Requero Á; Martínez A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
    Darrington RS; Campa VM; Walker MM; Bengoa-Vergniory N; Gorrono-Etxebarria I; Uysal-Onganer P; Kawano Y; Waxman J; Kypta RM
    Int J Cancer; 2012 Sep; 131(6):E872-83. PubMed ID: 22539113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.